Medical management of idiopathic calcium stone disease

Urinary Tract Stone Disease

Volumn , Issue , 2011, Pages 667-672

  Sterrett, Samuel P ^a   Nakada, Stephen Y ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892249610     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-362-0_56     Document Type: Chapter

References (43)

1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-1823.
2. Johnson CM, Wilson DM, O'Fallon WM, et al. Renal stone epidemiology: a 25 year study in Rochester, MN. Kidney Int. 1979;16:624-631.
3. Lotan Y, Pearle MS. Economics of stone management. Urol Clin N Am. 2007;34:1-13.
4. Clark JY, Thompson IM, Optenberg SA. Economic impact of urolithiasis in the United States. J Urol. 1995;154:2020-2024.
5. Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin N Am. 2007;31:323-334.
6. Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991;18:624-637.
7. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-838.
8. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497-504.
9. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;143:240-247.
10. Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982;72:17-24.
11. Wein A. Campbell's Urology. Philadelphia: Elsevier; 2008:1411.
12. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996;156:907-909.
13. Penniston KL, Steele TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology. 2007;70:856-860.
14. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol. 2006;1:1269-1274.
15. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stone. Am J Epidemiol. 1996;143:240-247.
16. Massey LK, Sutton RA. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol. 2004;172:555-558.
17. Stoller ML, Rubenstein JN. Rethinking urolithiasis. J Urol. 2005;173:1452.
18. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993;150(pt 1):310-312.
19. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95:791-797.
20. Penniston KL, Nakada SY. Preventive management of recurrent urolithiasis: medical and dietary approaches. Sem Prev Alt Med. 2007;3:67-73.
21. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84.
22. Seiner R, Schade N, Nicolay C, et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005;173:1601-1605.
23. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402-2410.
24. Pak CY, Heller HJ, Pearle MS, et al. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol. 2003;169:465-469.
25. Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W, et al. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen. Maturitas. 2002;41:149-156.
26. Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, et al. Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int. 2004;65:1835-1841.
27. Sakhaee K, Poindexter JR, Griffith CS, Pak CY. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172:958-961.
28. Penniston KL, Nakada SY, Hansen KE. Vitamin D repletion does not alter urinary calcium excretion in postmenopausal women. AUA, Abstract 2008.
29. Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation. Urol Res. 2004;32:311-316.
30. Krishnamurthy MS, Hruska KA, Chandhoke PS. The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol. 2003;169:2030-2033.
31. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225-3232.
32. Massey LK, Liebman M, Kynast-Gales SA. Ascorbate increases human oxaluria and kidney stone risk. J Nutr. 2005;135:1673-1677.
33. Borghi L, Meschi T, Guerra A, et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993;22:S78-S86.
34. Grobbee DE, Hoes AW. Non potassium sparing diuretics and risk of sudden cardiac death. J Hypertens. 1995;13:1539-1545.
35. Ohkawa M, Tokunaga S, Nakashima T, et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol. 1992;69:571-576.
36. Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988;139:679-684.
37. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215:383-389.
38. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13:679-685.
39. Barcelo P, Wuhl O, Servitge E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150:1761-1764.
40. Pak CY, Peterson R. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med. 1986;146(5):863-867.
41. Ettinger B. Hyperuricosuria and calcium oxalate lithiasis: a critical review and future outlook. in: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, eds. Kidney Stones. Parma, Italy: Editoriale Bios; 1999:51-57.
42. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386-1389.
43. Breslau NA, Heller HJ, Reza-Albarran AA, et al. Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial. J Urol. 1998;160:664-668.